We examined the dynamic range for tumour detection in Kras+/LSL-G12D mice at 40 weeks postinfection (p.i.)with Ad5-mSPC-Cre by comparing the tumour burden at endpoint using histology and micro-CT (Fig. 1A). This evidence concerns the gene KRAS and neoplasm.